A. Bhatt

Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancer

K. Nephew, D. Rusch, Jane E. Cavanaugh, 2021, Oncoscience.

Molecular Mechanisms of Epithelial to Mesenchymal Transition Regulated by ERK5 Signaling

Jane E. Cavanaugh, M. Burow, L. Miele, 2021, Biomolecules.

ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer

K. Nephew, L. Del Valle, Jane E. Cavanaugh, 2020, Frontiers in Oncology.

Dual inhibition of MEK1/2 and MEK5 suppresses the EMT/migration axis in triple‐negative breast cancer through FRA‐1 regulation

K. Nephew, D. Rusch, D. Chrisey, 2021, Journal of cellular biochemistry.

Novel Diphenylamine Analogs Induce Mesenchymal to Epithelial Transition in Triple Negative Breast Cancer

Jane E. Cavanaugh, M. Burow, Mohit Gupta, 2019, Front. Oncol..

Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple‐negative breast cancer

Jane E. Cavanaugh, M. Burow, Mohit Gupta, 2020, Journal of cellular biochemistry.

Diverse and converging roles of ERK1/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer

Jane E. Cavanaugh, M. Burow, L. Miele, 2021, Translational oncology.

ZBTB18 restricts chromatin accessibility and prevents transcriptional adaptations that drive metastasis

Beisi Xu, D. Finkelstein, Benjamin A. Minden-Birkenmaier, 2023, Science advances.